文献速递术前评估与围术期医学疼痛医学

基线检验的持久谬误:麻醉学与疼痛试验的元研究

The Enduring Table 1 Fallacy: A Meta-research Study of Baseline Testing in Anesthesiology and Pain Trials.
PubMed 文献 · Anesthesiology · 2025-09-25

该元研究分析1996至2025年间101本麻醉学与疼痛医学期刊的平行组随机对照试验,发现48.3%报告了基线特征统计检验,其中19.2%报告至少一项显著差异,且该做法未随时间下降,提示对随机化的持续误解。

要点

  • 近半数麻醉学随机对照试验仍对基线特征进行统计检验
  • 基线检验报告显著差异的比例未随时间下降
  • 作者团队规模较大与基线检验几率降低相关

核心结论

  • 尽管有方法学指南和CONSORT建议,麻醉学随机对照试验中基线特征统计检验仍常见且未随时间下降。

研究设计与样本

  • 元研究纳入1996至2025年Scopus麻醉学与疼痛医学分类下101本期刊的平行组随机对照试验,共2453项合格试验。

主要发现

  • 2453项试验中1186项(48.3%)报告了基线特征统计检验。
  • 进行基线检验的研究中228项(19.2%)报告至少一项统计学显著差异,58项(25.4%)将其作为研究局限性讨论。
  • 共检验11516个变量,424个(3.7%)报告为统计学显著,低于5%的随机预期(P < 0.001)。
  • 作者团队较大与基线检验几率降低相关(比值比0.95;95%CI 0.93至0.97)。
  • 检验变量数量较多增加发现至少一项显著差异的几率(比值比1.10;95%CI 1.07至1.12)。

临床怎么用

  • 麻醉科医生解读随机对照试验时应避免以基线检验P值判断组间可比性。
  • 报告和审稿时应遵循CONSORT建议,不对基线特征进行统计检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized controlled trials (RCTs) are designed to achieve balanced distribution of baseline characteristics across study arms through random allocation, rendering null-hypothesis significance testing on these characteristics unnecessary and potentially misleading. Despite longstanding guidance discouraging this practice, its prevalence and patterns within anesthesiology and pain medicine literature remain unclear. METHODS: The authors conducted a meta-research study of parallel-group RCTs published from 1996 to 2025 across 101 journals indexed under the "Anesthesiology and Pain Medicine" category in Scopus (Elsevier, The Netherlands). Data extraction included study characteristics, reporting of baseline testing, number of variables tested, and statistical significance. Multivariable logistic regression was used to identify factors associated with baseline testing, and a binomial test assessed whether the observed rate of significant findings exceeded the expected false-positive rate under the null hypothesis. RESULTS: Of 2,453 eligible RCTs, 1,186 (48.3%) reported statistical testing of baseline characteristics. Among studies performing such testing, 228 (19.2%) reported at least one statistically significant difference, and 58 (25.4%) discussed it as a study limitation. A total of 11,516 variables were tested, with 424 (3.7%) reported as statistically significant-below the 5% expected by chance ( P < 0.001). Larger author teams were associated with lower odds of baseline testing (odds ratio, 0.95; 95% CI, 0.93 to 0.97), while a higher number of variables tested increased the odds of finding at least one significant difference (odds ratio, 1.10; 95% CI, 1.07 to 1.12). CONCLUSIONS: Despite methodologic guidance and Consolidated Standards of Reporting Trials (CONSORT) recommendations, statistical testing of baseline characteristics remains common in anesthesiology RCTs and has not declined over time. This practice likely reflects persistent misunderstanding of randomization and may lead to misinterpretation of study validity. Education and stronger editorial policies are needed to align reporting behavior with best practices and improve trial transparency.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. De Cassai A, Dost B, Turunc E, et al. The Enduring Table 1 Fallacy: A Meta-research Study of Baseline Testing in Anesthesiology and Pain Trials. Anesthesiology. 2025. PMID: 40997084. doi:10.1097/ALN.0000000000005776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。